Tài liệu CLINICAL PHARMACOLOGY 2003 (PART 4) pptx
Tài liệu CLINICAL PHARMACOLOGY 2003 (PART 14) pptx
... 1997 Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clinical Microbiology Reviews 10: 781-791 Diekema D J, Jones R N 2001 Oxazolidine ... protein synthesis Aminoglycosides In the purposeful search that followed the demon- stration of the clinical efficacy of penicillin, strepto- mycin was obtained from Streptom...
Ngày tải lên: 22/01/2014, 00:20
Tài liệu CLINICAL PHARMACOLOGY 2003 (PART 16) pptx
... the parasite fails to develop in the mosquito (site 4). In summary, drugs may be selected for: • treatment of clinical attacks • prevention of clinical attacks • radical cure. Drugs used ... to AmBisome if the patient's renal function deteriorates. Further clinical trials are needed to establish the best clinically and cost effective ways to use...
Ngày tải lên: 22/01/2014, 00:20
Tài liệu CLINICAL PHARMACOLOGY 2003 (PART 21A) pptx
... of limited value clinically as they are very heterogenous. A classification by receptor binding profiles is likely to emerge with growing evidence on the clinical importance ... thioridazine (CYP 2D6), fluoxetine + sertindole (CYP 3A4) and fluvoxamine + olanzapine (CYP 1A2) but others, e.g. fluoxetine + quetiapine (CYP 3A4) appear to be of less significance....
Ngày tải lên: 26/01/2014, 19:20
Tài liệu CLINICAL PHARMACOLOGY 2003 (PART 25A) pptx
... Pharmacodynamic (Table 23.1). The associated properties (partial agonist action and membrane stabilising action) have only minor clinical importance with current drugs at doses ordinarily ... question is whether the differences between selective and nonselective -blockers constitute clinical advan- tages. In theory 1 -blockers are less likely to cause bronchoconstricti...
Ngày tải lên: 26/01/2014, 19:20
